<div class="embed-responsive embed-responsive-16by9"><iframe width="640" height="360" style="max-width: 100%;max-height: 100%; border:none;" src="https://oncologytube.com/videoEmbed/29014/phase-2-study-of-cemiplimab-response-rate-of-49-estimated-pfs-is-18-5-months-estimated-median-os-at-2-years-is-70?channelName=AnnualCancerMeeting&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" frameborder="0" allowfullscreen="allowfullscreen" allow="autoplay" scrolling="no">iFrame is not supported!</iframe></div>

Phase 2 Study Of Cemiplimab: Response Rate Of 49 Estimated PFS Is 18.5 Months, Estimated Median OS At 2 Years Is 70

Name: Phase 2 Study Of Cemiplimab: Response Rate Of 49 Estimated PFS Is 18.5 Months, Estimated Median OS At 2 Years Is 70
Uploaded: 2019-06-04T03:06:52
Duration: 4 min 48 s
Description: Alexander Guminski MD Of The University of Sydney Discusses Phase 2 Study Of Cemiplimab: Response Rate Of 49 Estimated PFS Is 18.5 Months, Estimated Median OS At 2 Years Is 70.

00:04:48

Annual Meeting

4 years 163 Views

Share Add to Report 0 0

Embed (Iframe):

<div class="embed-responsive embed-responsive-16by9"><iframe width="640" height="360" style="max-width: 100%;max-height: 100%; border:none;" src="https://oncologytube.com/videoEmbed/29014/phase-2-study-of-cemiplimab-response-rate-of-49-estimated-pfs-is-18-5-months-estimated-median-os-at-2-years-is-70?channelName=AnnualCancerMeeting&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" frameborder="0" allowfullscreen="allowfullscreen" allow="autoplay" scrolling="no">iFrame is not supported!</iframe></div>

Embed (Object):

<div class="embed-responsive embed-responsive-16by9"><object width="640" height="360"><param name="movie" value="https://oncologytube.com/videoEmbed/29014/phase-2-study-of-cemiplimab-response-rate-of-49-estimated-pfs-is-18-5-months-estimated-median-os-at-2-years-is-70?channelName=AnnualCancerMeeting&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit="></param><param name="allowFullScreen" value="true"></param><param name="allowscriptaccess" value="always"></param><embed src="https://oncologytube.com/videoEmbed/29014/phase-2-study-of-cemiplimab-response-rate-of-49-estimated-pfs-is-18-5-months-estimated-median-os-at-2-years-is-70?channelName=AnnualCancerMeeting&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" allowscriptaccess="always" allowfullscreen="true" width="640" height="360"></embed></object></div>

Link (HTML):

<a href="https://oncologytube.com/v/29014?channelName=AnnualCancerMeeting"><img src="https://oncologytubecom.cdn.ypt.me/videos/video_190604030652_fd1e/video_190604030652_fd1e.jpg?cache=15669162711682794628">Phase 2 Study Of Cemiplimab: Response Rate Of 49 Estimated PFS Is 18.5 Months, Estimated Median OS At 2 Years Is 70</a>

Link (BBCode):

[url=https://oncologytube.com/v/29014?channelName=AnnualCancerMeeting][img]https://oncologytubecom.cdn.ypt.me/videos/video_190604030652_fd1e/video_190604030652_fd1e.jpg?cache=15669162711682794628[/img]Phase 2 Study Of Cemiplimab: Response Rate Of 49 Estimated PFS Is 18.5 Months, Estimated Median OS At 2 Years Is 70[/url]

Sign in now!

Permanent Link

URL Friendly (SEO)

Current Time (SEO)

Category:

Melanoma and Skin

Description:

Alexander Guminski MD Of The University of Sydney Discusses Phase 2 Study Of Cemiplimab: Response Rate Of 49 Estimated PFS Is 18.5 Months, Estimated Median OS At 2 Years Is 70.